| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |